# Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals

> **NCT01262092** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 30 (actual)

## Conditions studied

- Opioid Dependence
- Opioid Withdrawal
- Opioid Detoxification

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT01262092
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-12
- **Final completion:** 2012-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01262092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01262092, "Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01262092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*